HOME >> MEDICINE >> NEWS
Mouse studies reveal immune mechanism involved in bone loss caused by estrogen deficiency

ATLANTA- Scientists have uncovered in mice a key mechanism of the immune system involved in the bone loss that results from estrogen deficiency. If confirmed in human studies, the findings would demonstrate that postmenopausal osteoporosis is the result of an inappropriate immune response triggered by estrogen deficiency. The research also could help explain why estrogen deficiency appears to exacerbate autoimmune diseases, such as rheumatoid arthritis.

Results of the research will be published in the online edition of the Proceedings of the National Academy of Sciences the week of August 4. The study's senior author was Roberto Pacifici, MD, professor of medicine and director of the Division of Endocrinology at Emory University School of Medicine. Lead author was Simone Cenci, MD, now at the San Raffaele Scientific Institute in Milan, Italy. Other authors included Gianluca Toraldo and Oscar Sierra from Washington University School of Medicine and Barnes-Jewish Hospital in St. Louis, and M. Neale Weitzman, Cristiana Roggia and Wei Ping Qian from Emory School of Medicine.

Scientists already had discovered that bone loss caused by estrogen deficiency results from the overexpansion of T cells in the immune system. Immune T cells are known to produce a protein called tumor necrosis factor (TNF) that increases the formation of osteoclasts in rodents and humans cells that help cause the absorption and removal of bone. T cell proliferation is typically caused by the activation of T cells, but until now scientists have not understood exactly why and how estrogen deficiency causes the T cells to become activated. In order to model postmenopausal estrogen deficiency, the scientists removed the ovaries from mice, then studied the mouse T cells in culture. They confirmed that T cell activation was jump started by the immune regulatory protein interferon gamma (IFN-g), which in turn stimulated a protein called class II transactivator (CIITA). They foun
'"/>

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University Health Sciences Center
4-Aug-2003


Page: 1 2

Related medicine news :

1. Mouse model reveals potential way to reduce cardiac deaths in kidney patients
2. Mouse gene shows new mechanism behind cardiac infarction in man
3. Mouse model gives insight to human hair loss
4. Mouse study: Signal overload in Alzheimer brains
5. Mouse shows how Rituximab removes human B cells
6. Mouse study could aid vaccine designers
7. Mouse model mimics real-world plague infection
8. Mouse antibodies thwart SARS virus
9. Mouse model of neuromuscular disease identifies key player in motor neuron death
10. Mouse study gives new view of anthrax toxin
11. Mouse provides clues about chronic pain

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/19/2017)... (PRWEB) , ... September 19, 2017 , ... ... Compliance and Safety for the President’s Malaria Initiative (PMI) Africa Indoor Residual ... Innovation to Action Award. , The Innovation to Action Award, a USAID ...
(Date:9/19/2017)... ... 2017 , ... MelaKids, a Laredo-based company, has introduced a new concept for ... Nature gives us a full supply of melanin – in the back of the ... glare-reducing pigment; however, around the age of thirty, we develop a yellow-brown pigment in ...
(Date:9/19/2017)... ... 19, 2017 , ... The Workgroup for Electronic Data Interchange (WEDI) , ... in healthcare information exchange and a trusted advisor to the U.S. Department of Health ... entitled Barriers to Adoption of the ERA and EFT Transactions . , ...
(Date:9/19/2017)... ... ... Public outrage over the toxins that exist in tap water and the ... industry itself to research, develop and ultimately supply consumers with healthy drinking water alternatives. ... natural alkaline water technologies, water filtration systems, and consumer education. ...
(Date:9/19/2017)... , ... September 19, 2017 , ... ... TX, announces the launch of its magnesium-based orthopedic medical device, OsteoCrete®. OsteoCrete® bone ... the first in the U.S. to incorporate magnesium, a critical property for bone ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)...  Medical professionals are expected to continuously ... their patients. Medical simulations offer clinicians the ... Simulation provides a safe method for teaching ... refine techniques and build confidence, without putting ... such as augmented reality, will now provide ...
(Date:9/6/2017)... Sept. 6, 2017 NeuroRx, a clinical stage biopharma ... and Behavior (ASIB), has been granted Fast Track status by ... of NRX-100 (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). ... trial of this sequential therapy targeting patients who are admitted ... ...
(Date:9/5/2017)... Colo. , Sept. 5, 2017 Sapheneia ... XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party Vendor ... existing CT scanners and allows compliance with current MITA ... Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically designed ... and alerts of potential radiation doses over a predefined ...
Breaking Medicine Technology:
Cached News: